@prefix orcid: .
@prefix this: .
@prefix sub: .
@prefix np: .
@prefix rdf: .
@prefix xsd: .
@prefix rdfs: .
@prefix ns2: .
@prefix ns1: .
@prefix prov: .
@prefix ns3: .
@prefix npx: .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo .
}
sub:assertion {
ns1:lead .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2021-12-16T19:48:03.115787"^^xsd:dateTime;
prov:wasGeneratedBy "S&T TWOC project version 2" .
sub:version prov:value "2"^^xsd:integer .
rdf:OBJECT rdfs:label "to lower risk of mortality with an odds ratio ( OR ) of 0.85 ( 95 % CrI" .
rdf:OBJECT-POSITION rdfs:label "34"^^xsd:integer .
rdf:PREDICATE rdfs:label "led" .
rdf:PREDICATE-POSITION rdfs:label "[105]" .
rdf:SUBJECT rdfs:label "dexamethasone" .
rdf:SUBJECT-POSITION rdfs:label "91"^^xsd:integer .
rdfs:ABSTRACT-UID ns2:50 "bls5qllx" .
rdfs:SENTENCE rdfs:label "Compared with the standard of care (SOC), Bayesian network meta-analysis (NMA) showed that dexamethasone led to lower risk of mortality with an odds ratio (OR) of 0.85 (95% CrI [0.76, 0.95]; moderate certainty) and lower risk of mechanical ventilation (MV) with an OR of 0.68 (95% CrI [0.56, 0.83]; low certainty)." .
rdfs:TRIPLE-UID ns3:bls5qllx-TRIPLE-ABSTRACT-3 "bls5qllx-TRIPLE-ABSTRACT-3" .
rdfs:label "dexamethasone" .
rdfs:label "odds ratio" .
}
sub:pubInfo {
sub:assertion prov:wasDerivedFrom .
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB";
npx:hasSignature "SamzKW+4xAp+52ySIDk3ggdUpq9j7WhypE2G9Fux6HlJR7X6S4BTvTW9izLQsV8ktHr4t0CjRZk89d3Pg7wsaoed15llA+STLSrsySBcIZyVKiozPmgJPs8cOAPpmlvO5KdyZxfYNZZL7oaGN5alVXai+p0/kBUqVO1r8dIZVv0=";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2021-12-16T19:48:03.115787"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-8954-0470 .
}